Mitochondrial DNA in inflammation and immunity

JS Riley, SWG Tait - EMBO reports, 2020 - embopress.org
Mitochondria are cellular organelles that orchestrate a vast range of biological processes,
from energy production and metabolism to cell death and inflammation. Despite this …

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

FA Zucca, J Segura-Aguilar, E Ferrari, P Muñoz… - Progress in …, 2017 - Elsevier
There are several interrelated mechanisms involving iron, dopamine, and neuromelanin in
neurons. Neuromelanin accumulates during aging and is the catecholamine-derived …

Genetics of Parkinson's disease

CM Lill - Molecular and cellular probes, 2016 - Elsevier
Almost two decades after the identification of SNCA as the first causative gene in
Parkinson's disease (PD) and the subsequent understanding that genetic factors play a …

[HTML][HTML] Exploring the journey of emodin as a potential neuroprotective agent: novel therapeutic insights with molecular mechanism of action

S Mitra, J Anjum, M Muni, R Das, A Rauf, F Islam… - Biomedicine & …, 2022 - Elsevier
Emodin is an anthraquinone derivative found in the roots and bark of a variety of plants,
molds, and lichens. Emodin has been used as a traditional medication for more than 2000 …

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

SR Subramaniam, MF Chesselet - Progress in neurobiology, 2013 - Elsevier
Parkinson's disease (PD) is a movement disorder that is characterized by the progressive
degeneration of dopaminergic neurons in substantia nigra pars compacta resulting in …

Phosphatidylethanolamine metabolism in health and disease

E Calzada, O Onguka, SM Claypool - … review of cell and molecular biology, 2016 - Elsevier
Phosphatidylethanolamine (PE) is the second most abundant glycerophospholipid in
eukaryotic cells. The existence of four only partially redundant biochemical pathways that …

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

DP Narendra, SM **, A Tanaka, DF Suen… - PLoS …, 2010 - journals.plos.org
Loss-of-function mutations in PINK1 and Parkin cause parkinsonism in humans and
mitochondrial dysfunction in model organisms. Parkin is selectively recruited from the …

Protective and toxic roles of dopamine in Parkinson's disease

J Segura‐Aguilar, I Paris, P Muñoz… - Journal of …, 2014 - Wiley Online Library
The molecular mechanisms causing the loss of dopaminergic neurons containing
neuromelanin in the substantia nigra and responsible for motor symptoms of Parkinson's …

The genetic background of Parkinson's disease: current progress and future prospects

K Kalinderi, S Bostantjopoulou… - Acta Neurologica …, 2016 - Wiley Online Library
Almost two decades of genetic research in Parkinson's disease (PD) have remarkably
increased our knowledge regarding the genetic basis of PD with numerous genes and …

Advances in the genetics of Parkinson disease

J Trinh, M Farrer - Nature Reviews Neurology, 2013 - nature.com
Parkinson disease (PD) is a multifactorial neurodegenerative disease that was long
considered the result of environmental factors. In the past 15 years, however, a genetic …